Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share Price near 52-week high after 1.02% rise

Aarey Drugs & Pharmaceuticals Share Price is at Rs 108.5, up 1.02% today, and remains near its 52-week high with a market capitalisation of Rs 343.94 crore as of 08 October 2026 at 10:22 AM IST.

Aarey Drugs & Pharmaceuticals Share Price is trading at Rs 108.5, higher by 1.02% from the previous close, and the move leaves the stock near its 52-week high with a market capitalisation of Rs 343.94 crore. As of 08 October 2026 at 10:22 AM IST, the latest Univest data confirms a near 52-week high event, but it does not establish a company-specific catalyst. For readers tracking Aarey Drugs & Pharmaceuticals Share Price today, the main point is simple: the stock is trading close to its yearly high while remaining within the day’s range. That keeps Aarey Drugs & Pharmaceuticals Stock News relevant for market watchers who follow share price action, valuation and sector comparison rather than short-term speculation.

Aarey Drugs & Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 108.5
Previous Close	Rs 107.4
Today's Move	+Rs 1.1 (+1.02%)
Open	Rs 107.4
High	Rs 108.5
Low	Rs 104.5
Market Capitalisation	Rs 343.94 crore

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) traded at Rs 108.5 versus the previous close of Rs 107.4, a rise of 1.02%. The stock opened at Rs 107.4, reached a high of Rs 108.5 and touched a low of Rs 104.5.

Aarey Drugs & Pharmaceuticals Share Price today opened at Rs 107.4, matched the same level as the previous close at the open, touched an intraday high of Rs 108.5 and a low of Rs 104.5. The stock is last traded at Rs 108.5, which is Rs 1.1 above the previous close of Rs 107.4. That places Aarey Drugs & Pharmaceuticals Share Price very close to its 52-week high zone without implying any fresh record. The day range shows that price moved between Rs 104.5 and Rs 108.5 while the latest print stayed at the top end of that band. For Aarey Drugs & Pharmaceuticals Share Price Live tracking, the key fact is that the stock remains near its one-year high as part of today’s broader Aarey Drugs & Pharmaceuticals Share Price update.

The latest Univest figures confirm a price event, but they do not establish why the move occurred. That makes Aarey Drugs & Pharmaceuticals Stock News a data-led update rather than a catalyst-led story. Investors following Aarey Drugs & Pharmaceuticals Share News may therefore focus on the exact price position, the near-52-week-high setup and the broader financial context before making sense of the move.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 343.94 crore
P/E Ratio	82.36x
P/B Ratio	2.03x
ROE	3.02%
ROCE	6.38%
EPS	Rs 1.3
Book Value Per Share	Rs 53.01
Dividend Yield	0%

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) fundamental metrics show P/E 82.36x, P/B 2.03x, ROE 3.02%, ROCE 6.38%. These figures provide context only and are not a buy or sell signal.

Aarey Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 343.94 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.36x, P/B at 2.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.02% and ROCE of 6.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.3, book value per share of Rs 53.01, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.14x, median ROE of 4.09%, median ROCE of 6.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	82.36x
Benchmark Median P/E	13.14x
Benchmark Average P/E	81.2x
Benchmark P/E Range	0x to 8,514.32x
Company P/B Ratio	2.03x
Benchmark Median P/B	1.32x
Company ROE	3.02%
Benchmark Median ROE	4.09%
Company ROCE	6.38%
Benchmark Median ROCE	6.04%
Company Market Capitalisation	Rs 343.94 crore
Benchmark Median Market Cap	Rs 53.14 crore

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) is classified under sector: Trading and industry: Trading.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 82.36x, which is above the benchmark median of 13.14x, a difference of +526.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROE of 3.02%, which is below the benchmark median of 4.09%, a difference of -26.16%. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROCE of 6.38%, which is above the benchmark median of 6.04%, a difference of +5.63%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Mishtann Foods Ltd.	MISHTANN	343.76	1.92	0.26	100.88	88.74
Gretex Industries Ltd.	GRETEX	343.34	233.2	6.03	4.26	3.58
Monika Alcobev Ltd.	MONIKA	350.17	10.89	1.43	18.89	14.67
Agribio Spirits Ltd.	AGRIBIO	334.47	79.08	4.7	6.48	7.16
HCL Infosystems Ltd.	HCLINSYS	333.16	0	-1.06	0	-54.82

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 82.36x compared with the displayed peer median of 10.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.02% compares with a peer median of 6.48% across the companies shown in the table. ROCE stood at 6.38% versus the displayed peer median of 7.16%, providing a capital-efficiency comparison. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a market capitalisation of Rs 343.94 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Aarey Drugs & Pharmaceuticals

• Aarey Drugs & Pharmaceuticals Share Price is trading at Rs 108.5, above the previous close of Rs 107.4.
• The stock remains near its 52-week high and one-year high zone.
• Aarey Drugs & Pharmaceuticals Market Cap stands at Rs 343.94 crore.
• The stock’s P/E is 82.36, while P/B is 2.03 and EPS is Rs 1.3.
• ROE is 3.02% and ROCE is 6.38%, which gives Aarey Drugs & Pharmaceuticals Fundamental Analysis a clear comparison point.

About Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd. is classified under the Trading sector and Trading industry in the latest Univest record for Aarey Drugs & Pharmaceuticals Share Price. The company is tracked on NSE and BSE market pages through its stock identity, and its current valuation data is being followed by readers looking at Aarey Drugs & Pharmaceuticals Stock News and Aarey Drugs & Pharmaceuticals Company News. For investors scanning Aarey Drugs & Pharmaceuticals Share Price Today, the company profile is best understood through the listed market, valuation and performance metrics that accompany the share price update.

Frequently Asked Questions

Why is Aarey Drugs & Pharmaceuticals Share Price in focus today?

Ans. Aarey Drugs & Pharmaceuticals Share Price is in focus because it is trading at Rs 108.5, up 1.02% from the previous close, and remains near its 52-week high.

What is Aarey Drugs & Pharmaceuticals Share Price today?

Ans. Aarey Drugs & Pharmaceuticals Share Price is Rs 108.5 as of 08 October 2026 at 10:22 AM IST. The stock is trading above the previous close of Rs 107.4.

How far is Aarey Drugs & Pharmaceuticals Share Price from its yearly high zone?

Ans. Aarey Drugs & Pharmaceuticals Share Price is near its 52-week high zone because the day’s high is Rs 108.5 and the latest trade is at the same level, leaving it close to the yearly high area.

What does Aarey Drugs & Pharmaceuticals Fundamental Analysis show?

Ans. Aarey Drugs & Pharmaceuticals Fundamental Analysis shows a market cap of Rs 343.94 crore, P/E of 82.36, P/B of 2.03, ROE of 3.02% and ROCE of 6.38%, with EPS at Rs 1.3.

Is Aarey Drugs & Pharmaceuticals Stock News linked to a stated catalyst?

Ans. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. Aarey Drugs & Pharmaceuticals Stock News is therefore being read through price and valuation data.

How does Aarey Drugs & Pharmaceuticals Share Price compare with sector benchmarks?

Ans. Aarey Drugs & Pharmaceuticals Share Price trades at a P/E of 82.36 versus the sector median of 13.14 and a P/B of 2.03 versus the sector median of 1.32 in the same industry set.

What does Aarey Drugs & Pharmaceuticals Share Price say about market capitalisation?

Ans. Aarey Drugs & Pharmaceuticals Share Price corresponds to a market capitalisation of Rs 343.94 crore. That places it above the same-industry median market cap of Rs 53.14 crore.

Where can I track Aarey Drugs & Pharmaceuticals Share Price update and stock analysis?

Ans. You can track Aarey Drugs & Pharmaceuticals Share Price update on Univest, where live price, 52-week levels, valuation ratios and company financials are presented together for easier review.

Track Aarey Drugs & Pharmaceuticals Share Price on Univest

Use Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Aarey Drugs & Pharmaceuticals Share Price Live on Univest for the latest price, 52-week levels, market capitalisation, valuation ratios and company financials. Univest also presents Aarey Drugs & Pharmaceuticals Stock Analysis, Aarey Drugs & Pharmaceuticals Fundamental Analysis and Aarey Drugs & Pharmaceuticals Stock Performance in one place so that market updates stay easy to review.